Zepp Health Reports Strong Q4 & FY25 Revenue Growth, Record Margins, and Narrowed Losses; Issues Positive Q1 2026 Outlook
ZEPP has more than doubled off its 52-week low of $2.125.
Summary
Zepp Health reported strong Q4 and full year 2025 financial results, including significant revenue growth, record gross margins, and a substantial reduction in net losses, alongside positive revenue guidance for Q1 2026.
Key Events · Earnings and Guidance · ZEPP
-
Strong Q4 and Full Year 2025 Revenue Growth
Fourth quarter 2025 revenue reached US$85.2 million, representing 43.0% year-over-year growth. Full year 2025 revenue grew 41.8% year-over-year to US$258.9 million, driven by Amazfit-branded products.
-
Record High Gross Margin Achieved
Gross margin for Q4 2025 reached a company-record level of 40.4%, an impressive expansion of 3.6 percentage points year-over-year, primarily due to a favorable product mix and sustained pricing power.
-
Significant Reduction in Net Loss
GAAP net loss for Q4 2025 narrowed by 70.2% year-over-year to US$11.0 million, and adjusted net loss narrowed by 71.6% to US$6.4 million. Full year adjusted net loss decreased from US$56.7 million in 2024 to US$31.5 million in 2025.
-
Positive Q1 2026 Revenue Guidance
Management expects net revenues for the first quarter of 2026 to be between US$50.0 million and US$55.0 million, representing a year-over-year increase of approximately 30% to 43%.
Analysis · ZEPP · Technology
Zepp Health Corporation delivered robust financial results for Q4 and full year 2025, showcasing significant operational improvements and strong growth momentum. The company achieved substantial year-over-year revenue growth, reaching a record-high gross margin, and significantly narrowed its net losses. The positive revenue guidance for Q1 2026, coupled with a healthy cash position and ongoing debt optimization, indicates a strong trajectory for the company. Investors should note the successful execution of its margin-expansion strategy and the strategic shift towards premium products, which are driving these positive trends.
How filings like this one have moved
In the 30 days to Sep 9, 2026, 36.4% of the 1919 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ZEPP was trading at $18.80 on NYSE in the Technology sector, with a market capitalization of approximately $299.3M. The 52-week trading range was $2.13 to $61.85. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.